Targeted Systemic Therapy clinical trials

A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor.

This study looks at a special type of strong radiation, called SABR, for people with a few small cancer spots that have spread, along with a main tumor. It compares SABR plus usual care to just usual care to see if it helps.